Lung cancer risk in mice: Analysis of fractionation effects and neutron RBE with a biologically motivated model

Radiation Research

Volumn 166, Issue 5, 2006, Pages 794-801

  Heidenreich, W F ^a   Carnes, B A ^b   Paretzke, H G ^a  

^a BUNDESAMT FÜR STRAHLENSCHUTZ   (Germany)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RISK; CONTROLLED STUDY; DOSE RESPONSE; GAMMA RADIATION; KINETICS; LUNG CANCER; MALE; MOUSE; NEUTRON; NONHUMAN; NONLINEAR SYSTEM; PRIORITY JOURNAL; RADIATION; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RELATIVE BIOLOGIC EFFECTIVENESS;

ANIMALS; BODY BURDEN; COMPUTER SIMULATION; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GAMMA RAYS; LUNG NEOPLASMS; MALE; MICE; MODELS, BIOLOGICAL; NEOPLASMS, RADIATION-INDUCED; NEUTRONS; RADIATION DOSAGE; RELATIVE BIOLOGICAL EFFECTIVENESS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 33750725147     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0481.1     Document Type: Article

References (23)

1. B. A. Carnes, D. Grahn and J. F. Thomson, Dose-response modeling of life shortening in a retrospective analysis of the combined data from the JANUS program at Argonne National Laboratory. Radiat. Res. 119, 39-56 (1989).
2. B. A. Carnes and D. Grahn, Issues about neutron effects: The JANUS program. Radiat. Res. 128 (Suppl.), S141-S146 (1991).
3. 1 mouse. Radiat. Res. 129, 19-36 (1992).
4. B. A. Carnes, N. Gavrilova and D. Grahn, Pathology effects of radiation doses below those causing increased mortality. Radiat. Res. 158, 187-194 (2002).
5. W. F. Heidenreich and H. G. Paretzke, City-effects in the atomic bomb survivors data atomic bomb survivors data. Math. Comput. Model. 33, 1431-1438 (2001).
6. S. H. Moolgavkar and G. Luebeck, Two-event model for carcinogenesis: Biological, mathematical, and statistical considerations. Risk Anal. 10, 323-341 (1990).
7. W. F. Heidenreich and H. G. Paretzke, Biologically based models of radiation-induced cancer. Radiat. Res. 156, 678-681 (2001).
8. E. G. Luebeck, W. F. Heidenreich, W. D. Hazelton, H. G. Paretzke and S. H. Moolgavkar, Biologically based analysis of the Colorado uranium miners cohort data: Age, dose and dose-rate effects. Radiat. Res. 152, 339-351 (1999).
9. W. F. Heidenreich, P. Jacob, H. G. Paretzke, F. T. Cross and G. E. Dagle, Two-step model for fatal and incidental lung tumor risk in rats exposed to radon. Radiat. Res. 151, 209-217 (1999).
10. 224Ra: Protraction effects from promotion. Radiat. Environ. Biophys. 44, 61-67 (2005).
11. D. Grahn, B. J. Wright, B. A. Carnes, F. S. Williamson and C. Fox, Studies of Acute and Chronic Radiation Injury at the Biological and Medical Research Division, Argonne National Laboratory, 1970-1992: The JANUS Program Survival and Pathology Data. Technical Report ANL-95/3, Argonne National Laboratory, Argonne, IL, 1995.
12. S. H. Moolgavkar, Carcinogenesis models: An overview. In Physical and Chemical Mechanisms in Molecular Radiation Biology (W. A. Glass and M. N. Varma, Eds.), pp. 387-395. Plenum Press, New York, 1991.
13. W. F. Heidenreich, E. G. Luebeck and S. H. Moolgavkar, Some properties of the hazard function of the two-mutation clonal expansion model. Risk Anal. 17, 391-399 (1997).
14. W. F. Heidenreich, Signals for a promoting action of radiation in cancer incidence data. J. Radiat. Prot. 22, A71-A74 (2002).
15. W. F. Heidenreich, J. Wellmann, P. Jacob and H. E. Wichmann, Mechanistic modelling in large case-control studies of lung cancer risk from smoking. Stat. Med. 21, 3055-3070 (2002).
16. W. F. Heidenreich, E. G. Luebeck, W. D. Hazelton, H. G. Paretzke and S. H. Moolgavkar, Multistage models and the incidence of cancer in the cohort of atomic bomb survivors. Radiat. Res. 158, 607-614 (2002).
17. F. James, MINUIT-Function Minimization and Error Analysis, Version 94.1. CERN, Geneva, 1994.
18. D. A. Pierce, Y. Shimizu, D. L. Preston, M. Vaeth and K. Mabuchi, Studies of the mortality of atomic bomb survivors Report 12, Part I. Cancer: 1950-1990. Radiat. Res, 146, 1-27 (1996).
19. D. L. Preston, Y. Shimizu, D. A. Pierce, S. Suyama and K. Mabuchi, Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 160, 381-407 (2003).
20. D. L. Preston, D. A. Pierce, Y. Shimizu, H. M. Cullings, S. Fujita, S. Funamoto and K. Kodama, Effects of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates. Radiat. Res. 162, 377-489 (2004).
21. National Research Council, Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation, Health Risks from Exposure to Low Levels of Ionizing Radiation (BEIR VII, Phase 2). National Academies Press, Washington, DC, 2006.
22. J. B. Storer and R. J. M. Fry, On the shape of neutron dose-effect curves for radiogenic cancers and life shortening in mice. Radiat. Environ. Biophys. 34, 21-27 (1995).
23. W. F. Heidenreich, U. Nyberg and P. Hall, A biologically based model for liver cancer risk in the Swedish Thorotrast patients. Radiat. Res. 159, 656-662 (2003).